Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon

EHJ: Cardiac MR is superior to SPECT for CAD detection

 Perfusion-cardiac MR (CMR) is a valuable alternative to SPECT forcoronary artery disease detection showing equal performance in ahead-to-head comparison, according to a MR-IMPACT trial published inthe February issue of the European Heart Journal.

Grand jury probes Biovail blood pressure drug

 Biovail has been notified by the U.S. Attorney's Office in Boston thatthe company is the target of a federal grand jury investigation inconnection with activities surrounding the 2003 commercial launch ofCardizem LA.

AJR: Automated visualization tool aids coronary CT angiography

Global left ventricular (LV) function is perhaps the strongestdeterminant of heart failure and death due to myocardial infarction.Traditionally, LV function studies conducted with CT have beenperformed with 2D planimetry of short-axis CT image reformations. Newadvances in automated advanced visualization 3D technology can producecomparable results to this methodology, according to a group of Germanresearchers.

Hope for infertility: Prototype allows MR, hysterosalpingography hybrid imaging

A team from the department of radiology at The Ottawa Hospital inOntario has added to the armamentarium of fusion imaging with thecreation and deployment of a MRI/radiography system.

JAMA: Heart attacks, deaths rise in first three months after Plavix cessation

 Among patients with ACS medically treated or PCI-treated, a clustering of adverse events in the initial three months after stopping clopidogrel (Plavix) can occur, supporting the possibility of its rebound effect, according to a study published in the Feb. 6 issue of the Journal of the American Medical Association.

Mercks Vioxx woes continue with $650M settlement

 Merck today has reached civil settlements for $649 million with federal and state authorities to resolve longstanding investigations related to fraudulent drug pricing and illegal kickbacks, as well as marketing practices for Vioxx and Zocor.

ISET: Peripheral arterial disease is more expensive to treat than CAD

Both coronary artery disease (CAD) and peripheral arterial disease(PAD) are atherosclerotic cardiovascular diseases involving blockedarteries, but it costs about 5 percent more to treat a PAD patient thanto treat a CAD patient, according to research presented at the 20thannual International Symposium on Endovascular Therapy (ISET) inHollywood, Fla.

NightHawk to provide radiology services for HRP Initiative

NightHawk Radiology has agreed to be the exclusive radiology providerfor the High-Risk Plaque (HRP) Initiative, a joint research effort toadvance the understanding and management of high-risk plaque.

Displaying 2609 - 2616 of 2637

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.